Search

The article discusses issues and market trends associated with drug reconstitution in the U.S. The drug reconstitution process poses several technical challenges to manufacturers including the lack of expertise, added risks, and compliance concerns. According to the author, pharmaceutical makers should consider factors when evaluating the alternatives for advanced reconstitution such as the type of drug, the administration method and time-to-market requirements. INSET: Making Challenging Medical Conditions a Little Easier.

The article provides tips for designing integrated drug delivery systems. Topics discussed include need to pay attention by pharmaceutical manufacturers on design, function, and efficacy of integrated delivery systems, need to consider interface between the drug, container, delivery device and patient before designing a drug delivery product and selecting a primary container for drugs.